Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2

International Journal of Cancer

Volumn 103, Issue 4, 2003, Pages 489-495

  Joos, Stefan ^a   Granzow, Martin ^b   Holtgreve Grez, Heidi ^b   Siebert, Reiner ^c   Harder, Lana ^c   Martín Subero, José I ^c   Wolf, Jürgen ^d   Adamowicz, Martyna ^a   Barth, Thomas F E ^e   Lichter, Peter ^a   Jauch, Anna ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Cytogenetic aberration; Hodgkin's lymphoma; JAK2; REL; Telomeric segment translocation

Indexed keywords

ARTICLE; CANCER GENETICS; CHROMOSOME 2P; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HODGKIN DISEASE; HUMAN; HUMAN CELL; JAK2 GENE; KARYOTYPE; LYMPHOMA CELL LINE; ONCOGENE; PRIORITY JOURNAL; REL GENE; TELOMERE;

CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 9; HODGKIN DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; JANUS KINASE 2; KARYOTYPING; MODELS, GENETIC; NUCLEIC ACID HYBRIDIZATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; TELOMERE; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0037428669     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10845     Document Type: Article

References (32)

1. Warnke RA, Weiss LM, Chan JKC, Cleary ML, Dorfman RF. Tumors of the lymph nodes and spleen. In: Rosai J, Sobin LH, eds. Atlas of Tumor Pathology. Washington DC: Armed Forces Institute of Pathology, 1995. 43-62.
2. Atkin NB. Cytogenetics of Hodgkin's disease. Cytogenet Cell Genet 1998;80:23-7.
3. Fonatsch C, Jox A, Streubel B, Wolf J, Diehl V. Cytogenetic findings in Hodgkin's disease cell lines. In: Mauch PMA, Diehl V, Hoppe RT, Weiss LM, eds. Hodgkin's Disease. Philadelphia: Lippincott Wiliams & Wilkins, 1999. 213-9.
4. + Hodgkin cells. Cancer Res 2000;60:549-52.
5. Ohshima K, Ishiguro M, Ohgami A, Sugihara M, Haraoka S, Suzumiya J, Kikuchi M. Genetic analysis of sorted Hodgkin and Reed-Sternberg cells using comparative genomic hybridization. Int J Cancer 1999;82:250-5.
6. Franke S, Wlodarska I, Maes B, Vandenberghe P, Delabie J, Hagemeijer A, De Wolf-Peeters C. Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances. Blood 2001;97:1845-53.
7. Joos S, Menz CK, Wrobel G, Siebert R, Gesk S, Ohl S, Mechtersheimet G, Trumper L, Moller P, Lichter P, Barth TF. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 2002;99:1381-7.
8. Drexler HG. The Leukemia-Lymphoma Cell Line Facts Book. San Diego: Academic Press, 2000.
9. Lichter P, Bentz M, du Manoir S, Joos S. Comparative genomic hybridization. In: Verma RS, Babu A, eds. Human Chromosomes. New York: McGraw-Hill, 1995. 191-210.
10. Joos S, Otaño-Joos MI, Ziegler S, Brüderlein S, du Manoir S, Bentz M, Möller P, Lichter P. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996;87:1571-8.
11. Speicher MR, Ballard GS, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 1996;12:368-75.
12. Eils R, Uhrig S, Saracoglu K, Satzler K, Bolzer A, Petersen I, Chassery J, Ganser M, Speicher MR. An optimized, fully automated system for fast and accurate identification of chromosomal rearrangements by multiplex-FISH (M-FISH). Cytogenet Cell Genet 1998;82:160-71.
13. Telenius H, Pelmear A, Tunnacliffe A, Carter N, Behmel A, Ferguson-Smith M, Nordenskjöld M, Pfragner R, Ponder B. Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer 1992;4:257-63.
14. ISCN. An International System for Human Cytogenetic Nomenclature. Farmington, CT: Karger, 1995.
15. Vocero-Akbani A, Helms C, Wang JC, Sanjurjo FJ, Korte-Sarfaty J, Veile RA, Liu L, Jauch A, Burgess AK, Hing AV, Holt MS, Ramachandra S, et al. Mapping human telomere regions with YAC and P1 clones: Chromosome-specific markers for 27 telomeres including 149 STSs and 24 polymorphisms for 14 proterminal regions. Genomics 1996;36:492-506.
16. Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL. Frequent translocation t(4; 14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 1997;16:260-4.
17. Cools J, Peeters P, Voet T, Aventin A, Mecucci C, Grandchamp B, Marynen P. Genomic organization of human JAK2 and mutation analysis of its JH2-domain in leukemia. Cytogenet Cell Genet 1999;85:260-6.
18. Albertsen H, Adderrahim H, Cann H, Dausset J, Le Paslier D, Cohen S. Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. Proc Natl Acad Sci USA 1990;87:4256-60.
19. Lichter P, Cremer T. Chromosome analysis by non-isotopic in situ hybridization. In: Rooney DE, Czepulkowski BH. Human cytogenetics. New York: Oxford University Press, 1992. 157-92.
20. Martin-Subero JI, Gesk S, Harder L, Sonoki T, Tucker PW, Schlegelberger B, Grote W, Novo FJ, Calasanz MJ, Hansmann ML, Dyer MJ, Siebert R. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 2002;99:1474-7.
21. Lengauer C, Green ED, Cremer T. Fluorescence in situ hybridization of YAC clones after Alu-PCR amplification. Genomics 1992;13:826-8.
22. Joos S, Lichter P. Comparative genomic hybridization. In: Spector D, ed. Cells - A Cold Spring Harbor Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1997 p. 112.1-112.11.
23. Du Manoir S, Schröck E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T. Quantitative analysis of comparative genomic hybridization. Cytometry 1995;19:27-41.
24. Solinas-Toldo S, Wallrapp C, Müller-Pillasch F, Bentz M, Gress T, Lichter P. Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 1996;56:3803-7.
25. Schlegelberger BMS, Harder S, Zühlke-Jenisch R, Zhang Y, Siebert R. Classical and molecular cytogenetics of tumor cells. In: Wegner RD, ed. Diagnostic Cytogenetics. Berlin: Springer-Verlag, 1999. 151-85.
26. Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, Liu H, Price HP, Gesk S, Steinemann D, Schlegelberger B, Oscier DG, et al. The BCL11 gene family: Involvement of BCL11A in lymphoid malignancies. Blood 2001;98:3413-20.
27. MacLeod RA, Spitzer D, Bar-Am I, Sylvester JE, Kaufmann M, Wernich A, Drexler HG. Karyotypic dissection of Hodgkin's disease cell lines reveals ectopic subtelomeres and ribosomal DNA at sites of multiple jumping translocations and genomic amplification. Leukemia 2000;14:1803-14.
28. Wolf J, Kapp U, Bohlen H, Kornacker M, Schoch C, Stahl B, Mucke S, von Kalle C, Fonatsch C, Schaefer H, Hansmann M, Diehl V. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin Reed-Sternberg cells. Blood 1996;8:3418-28.
29. Bargou R, Emmerich F, Krappmann D, Bommert K, Mapara M, Arnold W, Royer H, Grinstein E, Greiner A, Scheidereit C, Dorken B. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997;100:2961-9.
30. Meltzer P, Guan X, Trent G. Telomere capture stabilizes chromosome breakage. Nat Genet 1993;4:252-5.
31. Neubauer H, Cumano A, Muller M, Wu H, Huffstadt U, Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 1998;93:397-409.
32. Tanaka K, Arif M, Eguchi M, Kyo T, Dohy H, Kamada N. Frequent jumping translocations of chromosomal segments involving the ABL oncogene alone or in combination with CD3-MLL genes in secondary leukemias. Blood 1997;89:596-600.